119 related articles for article (PubMed ID: 37105033)
21. Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.
Yuan H; Jiang H; Wang Y; Dong Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142627
[TBL] [Abstract][Full Text] [Related]
22. Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.
Shuang Y; Yao X; Liu J; Niu J; Guo W; Li C
Hum Cell; 2022 Jul; 35(4):1084-1099. PubMed ID: 35545731
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p.
Yin X; Wang J; Shan C; Jia Q; Bian Y; Zhang H
Bioengineered; 2022 Mar; 13(3):6929-6941. PubMed ID: 35236250
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA ciRS-7 promotes laryngeal squamous cell carcinoma development by inducing TGM3 hypermethylation via miR-432-5p/DNMT3B axis.
Zhao K; Ye F; Gao P; Zhu X; Hao S; Lou W
Pathol Res Pract; 2022 Dec; 240():154193. PubMed ID: 36356335
[TBL] [Abstract][Full Text] [Related]
25. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
26. Competing endogenous RNA network analysis of CD274, IL‑10 and FOXP3 co‑expression in laryngeal squamous cell carcinoma.
Sun J; Lian M; Ma H; Wang R; Ma Z; Wang H; Zhai J; Meng L; Feng L; Bai Y; Cui X; Fang J
Mol Med Rep; 2018 Mar; 17(3):3859-3869. PubMed ID: 29257349
[TBL] [Abstract][Full Text] [Related]
27. Effect of CADM1 on TPF-induced chemotherapy in laryngeal squamous cell carcinoma.
Nie J; Li L; Tan F; Wang H; Wang H; Zou L; Wen Z
J Int Med Res; 2023 Apr; 51(4):3000605231168017. PubMed ID: 37114505
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑195 is associated with regulating the pathophysiologic process of human laryngeal squamous cell carcinoma.
Pang H; Xu X; Dai L; Wang K; Yao X
Mol Med Rep; 2018 Apr; 17(4):5283-5291. PubMed ID: 29393451
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression.
Liu DM; Yang H; Yuan ZN; Yang XG; Pei R; He HJ
Biochem Biophys Res Commun; 2020 Aug; 529(2):148-155. PubMed ID: 32703403
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.
Tang XZ; Zhou XG; Zhang XG; Li GS; Chen G; Dang YW; Huang ZG; Li MX; Liang Y; Yao YX; Chen XY; Rong MH; Huang SN
Cancer Biomark; 2020; 29(1):111-124. PubMed ID: 32623386
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA‑143‑3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k‑Ras/Raf/MEK/ERK signaling pathway.
Zhang F; Cao H
Int J Oncol; 2019 Feb; 54(2):689-701. PubMed ID: 30535502
[TBL] [Abstract][Full Text] [Related]
32. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1.
Liu Y; Liu J; Wang L; Yang X; Liu X
Mol Med Rep; 2017 Nov; 16(5):7154-7162. PubMed ID: 28901478
[TBL] [Abstract][Full Text] [Related]
35. LncRNA NCK1-AS1 Promotes Malignant Cellular Phenotypes of Laryngeal Squamous Cell Carcinoma via miR-137/NCK1 Axis.
Wan L; Gu D; Jin X
Mol Biotechnol; 2022 Aug; 64(8):888-901. PubMed ID: 35218517
[TBL] [Abstract][Full Text] [Related]
36. BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma.
Wang N; Huang X; Cheng J
PeerJ; 2022; 10():e12871. PubMed ID: 35178302
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
38. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
Liu C; Lu Z; Liu H; Zhuang S; Guo P
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
[TBL] [Abstract][Full Text] [Related]
39. The ETS1-LINC00278 negative feedback loop plays a role in COL4A1/COL4A2 regulation in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Wang JT; Yu MM; Wang BS
Neoplasma; 2022 Jul; 69(4):841-858. PubMed ID: 35532293
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-375 inhibits laryngeal squamous cell carcinoma progression via targeting CST1.
Dai F; Xie Z; Yang Q; Zhong Z; Zhong C; Qiu Y
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S108-S116. PubMed ID: 35953439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
